SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population

NCT07051603 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Hypertension

Interventions

DRUG: SAL0140
DRUG: SAL0140 placebo

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.